Guardian Pharmacy Services Inc (NYSE:GRDN)

Q1 2025 Guardian Pharmacy Services Inc Earnings Call Transcript

May 12, 2025 / 08:30 PM GMT

Release Date Price: $25.66 (+0.12%)

Transcript 10-Q8-K

Key Points

Positve

Guardian Pharmacy Services Inc (GRDN) reported a strong start to 2025 with a 20% increase in revenue, reaching $329 million.
The company saw a 15% increase in resident count, reaching approximately 189,000 by the end of the quarter.
Adjusted EBITDA grew by 16% to $23.4 million, indicating strong financial performance.
The acquisition pipeline is highly active, with several near-term opportunities on the horizon, suggesting potential for further growth.
Guardian Pharmacy Services Inc (GRDN) successfully closed an acquisition of a small pharmacy in Wichita, Kansas, expanding their market presence.

Negative

Integration costs, particularly from the Heartland acquisition, put pressure on Q1 profitability.
The transition of Heartland's IT operating infrastructure is expected to incur additional costs, impacting short-term financials.
10 of the 52 pharmacies are still in the early stages of integration, which is dilutive to operating profits in the first 2 to 3 years.
The potential impact of the Inflation Reduction Act and tariffs remains uncertain, posing a risk to future performance.
The company anticipates a full year of PUCO costs around $4 million in 2025, compared to just one quarter in 2024, affecting profitability.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GRDN.N - Guardian Pharmacy Services Inc
Q1 2025 Guardian Pharmacy Services Inc Earnings Call
May 12, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day everyone, and welcome to the Guardian Pharmacy's first quarter 2025 earnings call. This time, all participants are in a listen-only mode.

Later you will have the opportunity to ask a question during the question and answer session. If at any time during this call you require immediate assistance, please press 0 for the operator.

Today's speakers will be Fred Burke, President and CEO of Guardian Pharmacy, and David Morris, EVP and CFO of Guardian Pharmacy. Before we begin, I'd like to remind everyone that the statements included in this conference call and in the press release issued today may constitute forward-looking statements within the meaning of the Private Securities Litigation

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.